Cargando…

How to Decide Oxygen Therapy in Childhood Carbon Monoxide Poisoning?

OBJECTIVE: Carbon monoxide poisoning is an important cause of morbidity and mortality all over the world. In our study, it was aimed to determine the clinical and laboratory parameters that may be effective in deciding the need for hyperbaric oxygen therapy in the management of cases. MATERIALS AND...

Descripción completa

Detalles Bibliográficos
Autores principales: Uysalol, Metin, Gümüş, Sühelya, Yıldız, Raif
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Turkish Pediatrics Association 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10210599/
https://www.ncbi.nlm.nih.gov/pubmed/37144261
http://dx.doi.org/10.5152/TurkArchPediatr.2023.22189
_version_ 1785047098890125312
author Uysalol, Metin
Gümüş, Sühelya
Yıldız, Raif
author_facet Uysalol, Metin
Gümüş, Sühelya
Yıldız, Raif
author_sort Uysalol, Metin
collection PubMed
description OBJECTIVE: Carbon monoxide poisoning is an important cause of morbidity and mortality all over the world. In our study, it was aimed to determine the clinical and laboratory parameters that may be effective in deciding the need for hyperbaric oxygen therapy in the management of cases. MATERIALS AND METHODS: From January 2012 to the end of December 2019, 83 patients who applied to a university hospital pediatric emergency department in İstanbul with the diagnosis of carbon monoxide poisoning were included. Demographic characteristics, carbon monoxide source, exposure duration, treatment approach, physical examination findings, Glasgow Coma Score, laboratory results, electrocardiogram, cranial imaging, and chest x-ray were evaluated from the records. RESULTS: The median age of the patients was 56 (37.0-100.0) months and 48 (57.8%) of them were male. The median time of exposure to carbon monoxide was 5.0 (0.5-3.0) hours in those who received hyperbaric oxygen therapy and was significantly higher than those who received normobaric oxygen therapy (P < .001). Myocardial ischemia, chest pain, pulmonary edema, and renal failure were not detected in any of the cases. The median lactate level was detected as 1.5 (1.0-2.15) mmol/L in those who received normobaric oxygen therapy and 3.7 (3.17-4.62) mmol/L in those who received hyperbaric oxygen therapy, and the difference between them was statistically significant (P < .001). CONCLUSIONS: A guideline containing precise clinical and laboratory parameters for hyperbaric oxygen therapy in children has not been developed yet. In our study, carbon monoxide exposure duration, carboxyhemoglobin levels, neurological symptoms, and lactate levels were found to be guiding parameters in determining the need for hyperbaric oxygen therapy.
format Online
Article
Text
id pubmed-10210599
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Turkish Pediatrics Association
record_format MEDLINE/PubMed
spelling pubmed-102105992023-05-26 How to Decide Oxygen Therapy in Childhood Carbon Monoxide Poisoning? Uysalol, Metin Gümüş, Sühelya Yıldız, Raif Turk Arch Pediatr Original Article OBJECTIVE: Carbon monoxide poisoning is an important cause of morbidity and mortality all over the world. In our study, it was aimed to determine the clinical and laboratory parameters that may be effective in deciding the need for hyperbaric oxygen therapy in the management of cases. MATERIALS AND METHODS: From January 2012 to the end of December 2019, 83 patients who applied to a university hospital pediatric emergency department in İstanbul with the diagnosis of carbon monoxide poisoning were included. Demographic characteristics, carbon monoxide source, exposure duration, treatment approach, physical examination findings, Glasgow Coma Score, laboratory results, electrocardiogram, cranial imaging, and chest x-ray were evaluated from the records. RESULTS: The median age of the patients was 56 (37.0-100.0) months and 48 (57.8%) of them were male. The median time of exposure to carbon monoxide was 5.0 (0.5-3.0) hours in those who received hyperbaric oxygen therapy and was significantly higher than those who received normobaric oxygen therapy (P < .001). Myocardial ischemia, chest pain, pulmonary edema, and renal failure were not detected in any of the cases. The median lactate level was detected as 1.5 (1.0-2.15) mmol/L in those who received normobaric oxygen therapy and 3.7 (3.17-4.62) mmol/L in those who received hyperbaric oxygen therapy, and the difference between them was statistically significant (P < .001). CONCLUSIONS: A guideline containing precise clinical and laboratory parameters for hyperbaric oxygen therapy in children has not been developed yet. In our study, carbon monoxide exposure duration, carboxyhemoglobin levels, neurological symptoms, and lactate levels were found to be guiding parameters in determining the need for hyperbaric oxygen therapy. Turkish Pediatrics Association 2023-05-01 /pmc/articles/PMC10210599/ /pubmed/37144261 http://dx.doi.org/10.5152/TurkArchPediatr.2023.22189 Text en 2023 authors https://creativecommons.org/licenses/by-nc/4.0/ Content of this journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. (https://creativecommons.org/licenses/by-nc/4.0/)
spellingShingle Original Article
Uysalol, Metin
Gümüş, Sühelya
Yıldız, Raif
How to Decide Oxygen Therapy in Childhood Carbon Monoxide Poisoning?
title How to Decide Oxygen Therapy in Childhood Carbon Monoxide Poisoning?
title_full How to Decide Oxygen Therapy in Childhood Carbon Monoxide Poisoning?
title_fullStr How to Decide Oxygen Therapy in Childhood Carbon Monoxide Poisoning?
title_full_unstemmed How to Decide Oxygen Therapy in Childhood Carbon Monoxide Poisoning?
title_short How to Decide Oxygen Therapy in Childhood Carbon Monoxide Poisoning?
title_sort how to decide oxygen therapy in childhood carbon monoxide poisoning?
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10210599/
https://www.ncbi.nlm.nih.gov/pubmed/37144261
http://dx.doi.org/10.5152/TurkArchPediatr.2023.22189
work_keys_str_mv AT uysalolmetin howtodecideoxygentherapyinchildhoodcarbonmonoxidepoisoning
AT gumussuhelya howtodecideoxygentherapyinchildhoodcarbonmonoxidepoisoning
AT yıldızraif howtodecideoxygentherapyinchildhoodcarbonmonoxidepoisoning